Long-term surveillance study of rituximab originator treated patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA)

Long-term surveillance study of rituximab originator treated patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA)

Lay Summary: What does this mean for patients? Rituximab is used to treat active disease and to prevent relapses in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). Serious complications, including infections, low natural antibody levels, cancers, low white blood cell levels, heart...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Uchida, L, Jones, RB, Smith, RM, Nodale, M, Bond, S, Loechel, C, King, M, Luqmani, R, Gray, D, Barrett, J, Jayne, DRW
Natura:	Journal article
Lingua:	English
Pubblicazione:	Oxford University Press 2024

Documenti analoghi

Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis
di: Shah S, et al.
Pubblicazione: (2015-08-01)

Echocardiogram: The GPS to GPA’s Heart (Granulomatosis with Polyangiitis)
di: Manpreet K. Parmar, et al.
Pubblicazione: (2019-01-01)

Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis
di: Masayoshi Harigai, et al.
Pubblicazione: (2019-05-01)

An Unusual Presentation of Granulomatosis with Polyangiitis (GPA): Case Report
di: Sabrina Khuder, et al.
Pubblicazione: (2023-12-01)

Tension Pneumothorax as Initial Manifestation of Granulomatosis with Polyangiitis (GPA)
di: Rúben Reis, et al.
Pubblicazione: (2021-02-01)

Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
di: David Jayne, et al.
Pubblicazione: (2019-06-01)

Chemokine expression in sera of patients with microscopic polyangiitis and granulomatosis with polyangiitis
di: Ji Eun Lee, et al.
Pubblicazione: (2024-04-01)

Role of bronchoscopy for respiratory involvement in granulomatosis with polyangiitis and microscopic polyangiitis
di: Thomas Villeneuve, et al.
Pubblicazione: (2023-09-01)

Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis
di: Hervé Devilliers, et al.
Pubblicazione: (2023-03-01)

Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis
di: Candice Jamois, et al.
Pubblicazione: (2022-09-01)

An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis
di: Sujit Surendran, et al.
Pubblicazione: (2017-01-01)

THE RELATIONSHIP BETWEEN BRAIN WHITE MATTER CHANGES AND FATIGUE IN GRANULOMATOSIS WITH POLYANGIITIS (GPA; WEGENER'S)
di: Basu, N, et al.
Pubblicazione: (2012)

Granulomatosis with Polyangiitis (GPA)—A Multidisciplinary Approach of a Case Report
di: Cornelia M. Trandafir, et al.
Pubblicazione: (2022-12-01)

Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis.
di: Sung Soo Ahn, et al.
Pubblicazione: (2021-01-01)

Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis
di: Michele Iudici, et al.
Pubblicazione: (2016-10-01)

Successful rituximab treatment of granulomatosis with polyangiitis with cranial neuropathies
di: Maho Nakazawa, et al.
Pubblicazione: (2018-11-01)

Activation of natural killer cells by rituximab in granulomatosis with polyangiitis
di: Doris Urlaub, et al.
Pubblicazione: (2019-12-01)

Rituximab in Kidney-Limited Microscopic Polyangiitis
di: Anvitha Madhavaram, et al.
Pubblicazione: (2023-12-01)

Granulomatosis with polyangiitis
di: Yu Zhu, et al.
Pubblicazione: (2024-01-01)

Granulomatosis with polyangiitis
di: Zubayer Ahmad, et al.
Pubblicazione: (2016-12-01)

Efficacy and safety of belimumab in combination with azathioprine for remission maintenance in granulomatosis with polyangiitis and microscopic polyangiitis: a multicenter randomized, placebo-controlled study
di: Jayne, D, et al.
Pubblicazione: (2017)

A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis
di: Michele V. Quan, et al.
Pubblicazione: (2018-11-01)

Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis
di: Falk, R, et al.
Pubblicazione: (2011)

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
di: Falk, R, et al.
Pubblicazione: (2011)

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
di: Falk, R, et al.
Pubblicazione: (2011)

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
di: Falk, R, et al.
Pubblicazione: (2011)

Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis.
di: Samuel Deshayes, et al.
Pubblicazione: (2018-01-01)

Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
di: Wechsler, M, et al.
Pubblicazione: (2017)

Clinical characteristics of patients with granulomatosis with polyangiitis and microscopic polyangiitis in ENT practice: a comparative analysis
di: J. Wojciechowska, et al.
Pubblicazione: (2018-12-01)

Granulomatosis with polyangiitis in Tunisia
di: I. Ben Ghorbel, et al.
Pubblicazione: (2017-05-01)

Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1—treatment of granulomatosis with polyangiitis and microscopic polyangiitis
di: Sara Monti, et al.
Pubblicazione: (2023-07-01)

Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis
di: Jang Woo Ha, et al.
Pubblicazione: (2023-12-01)

Granulomatosis With Polyangiitis and Microscopic Polyangiitis: A Systematic Review and Meta‐Analysis of Benefits and Harms of Common Treatments
di: Jason M. Springer, et al.
Pubblicazione: (2021-03-01)

Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis
di: Kasia Owczarczyk, et al.
Pubblicazione: (2020-09-01)

Fibrosis-4 index at diagnosis is associated with all-cause mortality in patients with microscopic polyangiitis and granulomatosis with polyangiitis
di: Hee Jin Park, et al.
Pubblicazione: (2019-06-01)

Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis
di: Emilio Besada, et al.
Pubblicazione: (2015-06-01)

Successful treatment with rituximab and plasmapheresis of renal involvement of eosinophilic granulomatosis with polyangiitis
di: Ryuichi Yoshii, et al.
Pubblicazione: (2023-02-01)

Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi
di: Sei Adachi, et al.
Pubblicazione: (2022-02-01)

Clinical Characteristics of an Internet-Based Cohort of Patient-Reported Diagnosis of Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Observational Study
di: Springer, Jason Michael, et al.
Pubblicazione: (2020-07-01)

Digital Necrosis in Granulomatosis with Polyangiitis
di: Philipp Jud, et al.
Pubblicazione: (2023-01-01)